Clinical Advances in Radiation Therapy for Cancers

Dear Colleagues,

Radiation therapy remains a cornerstone in cancer treatment, continuously evolving through technological advancements and innovative therapeutic strategies. This Special Issue in explores the latest progress in radiation oncology, addressing key developments in radiotherapy techniques, radiobiology, and multimodal cancer treatment.

Recent innovations in proton therapy and heavy ion radiation oncology have improved treatment precision, reducing toxicity and enhancing patient outcomes. The integration of predictive and prognostic biomarkers enables personalized radiotherapy, optimizing efficacy and minimizing adverse effects. Advances in radiobiology contribute to a better understanding of tumor response and resistance mechanisms, guiding novel therapeutic strategies. Within multimodal therapeutic strategies, radiotherapy is combined with immunotherapy, targeted therapy, and chemotherapy to enhance anti-tumor efficacy.

In this Special Issue we welcome original research papers and reviews on emerging radiation therapy techniques, biomarker-driven radiation strategies, clinical applications of particle therapy, and novel combination therapies. We welcome papers reporting clinical trials of various dimensions; validating new radiation approaches and exploring their synergy with systemic treatments is also highlighted. Translational research papers on radiobiology and biomarker-based radiation or multimodal therapy indications are also welcome. 

Prof. Dr. Rodica Maricela Anghel
Dr. Liviu Bîlteanu
Dr. Laura Florentina Rebegea
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.